• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

China Resources Pharmaceutical Group Ltd.

Headquarters: Beijing, China
Year Founded: 2007
Status: Public
Industry Sector: HealthTechnology
CEO: Xiao Song Bai
Number Of Employees: 72,700
Enterprise Value: $18,734,697,668
PE Ratio: 9.94
Exchange/Ticker 1: HKEX:3320
Exchange/Ticker 2: N/A
Latest Market Cap: $3,883,001,000

BioCentury | Jun 17, 2025
Deals

AZ in AI discovery deal with China’s CSPC: Deals Report

Plus: Biontech acquiring fellow German mRNA play Curevac, Supernus buying Sage, and more
BioCentury | Jan 14, 2023
Finance

Jan. 13 Quick Takes: Stevens’ Structure Therapeutics files for IPO

Plus: Expanded label for Novo’s Rybelsus and updates from China Resources, LinusBio, MPC Therapeutics, Sabin and more
BioCentury | Apr 6, 2018
Finance

China’s exchange options

Comparing fast track pilot for mainland China listings to revamped HKEX
BioCentury | Jan 13, 2018
Finance

Choosy investors

Why 2018 will be a stock picker’s market in biotech
BioCentury | Oct 27, 2017
Financial News

China Resources planning China pharma fund

BioCentury | Oct 26, 2017
Financial News

China Resources planning China pharma fund

BioCentury | Dec 16, 2016
Company News

Sanofi, China Resources deal

BioCentury | Oct 31, 2016
Financial News

China Resources Pharmaceutical completes IPO

Items per page:
1 - 10 of 14